Chemotherapy Expert Witnesses in Alabama

This board-certified expert has extensive clinical and research experience in Urology, Urologic Oncology and da Vinci Robotic Surgery. He currently practices in Macon, GA (pop. 92,000). He received his MD from the Medical University of South Carolina following a BS from Brown University. He completed an Internship in General Surgery and a Residency in Urology at the Medical College of Virginia, where he was Chief Resident. The expert is a member of several professional societies and has received honors for his research. He has delivered multiple presentations in professional forums. He has published multiple articles in prestigious peer-reviewed journals, including Cancer Therapeutics and Oncology. He formerly served as Chief of Urology at Mercer University School of Medicine.

This highly qualified radiation oncology and medical physics expert has extensive experience in his field. He received his BS in nuclear engineering, his MS in medical physics and his PhD in Medical Physics all from The University of Tennessee, Knoxville. He holds board certifications in both medical physics and general radiology and radiologic physics. He has published over 30 journal articles and given over 100 peer-reviewed presentations related to topics in his field. He is a member of the American Association of Physicists in Medicine as well as the American College of Radiology. Currently, this expert serves as an adjunct associate professor of nuclear engineering at a top TN university, the director of medical physics at a TN cancer center and the founder of a TN radiation center.

This expert is Board Certified in Pediatric Hematology-Oncology and Pathology, completing Fellowships in Pediatric Hematology/Oncology/BMT and Transfusion Medicine at Emory University School of Medicine. She is a member of the American Academy of Pediatric Hematology/Oncology and the American Society of Hematology, and has 50 publications in the field of Pediatric Hematology/Oncology. She is a former Assistant Professor of Pathology and Pediatrics at Emory University, and currently is the Medical Director of Blood and Tissue Services, along with being an Associate Professor of both Pathology and Pediatrics at a top medical university.

This board certified expert has been practicing for over a decade. He earned a combined M.D.-Ph.D. from Virginia Commonwealth University prior to completing a residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at Seattle Children's Hospital. He holds membership in a multitude of prestigious medical organizations such as the American Society of Clinical Oncology and the American Society of Pediatric Hematology/Oncology, while he serves as a manuscript reviewer for over 10 medical journals, including "Cancer", "Frontiers in Pediatric Oncology", and "Annals of Oncology". Currently, this expert is an Associate Professor in the Division of Pediatric Hematology/Oncology at a major medical university, where he also serves as the Director of the Pediatric Sarcoma Program, the Adolescent and Young Adult Oncology Program, and the Pediatric Hematology/Oncology Fellowship Program.

This highly qualified, triple board certified doctor completed his medical school at the American University of Beirut (AUB). He subsequently joined the internal medicine residency program at Wayne State University. After completion of the residency, he joined the hematology oncology fellowship program at the Karmanos Cancer Institute, also at Wayne State University. He then joined faculty as an Assistant Professor in the area of GI oncology. During this time, he was involved in translational research focused on pancreatic cancer. Immediately following his time at Wayne state, this doctor moved to his current position at a GA university as the director of the GI Oncology program . He is designated as a Distinguished Cancer Scholar by the Georgia Cancer Coalition. He is also currently the medical director of the Clinical Trials Office, where his mission relies on translational projects related to gastrointestinal malignancies, specifically pancreatic and colorectal cancer, to bring observations derived from invitro models of cancer cell growth to the clinic. He has over 150 peer reviewed publications, and is the lead clinical investigator on at least eight trials focused on the evaluation of novel treatments in patients with early stage or advanced cancer.